{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T12:10:02Z","timestamp":1770639002932,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/igc.0b013e318218f270","type":"journal-article","created":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T03:24:35Z","timestamp":1306898675000},"page":"1063-1070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Surgical and Medical Treatment of Clear Cell Ovarian Cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"Francescapaola","family":"Magazzino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dionyssios","family":"Katsaros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Ottaiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angiolo","family":"Gadducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Sorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Rabaiotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"Cormio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Scarampi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Greggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Savarese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Marinaccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Scollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Pignata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e318218f270_bb0005","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1200\/JCO.1991.9.7.1138","article-title":"Long-term follow-up prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience","volume":"9","author":"Omura","year":"1991","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318218f270_bb0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0090-8258(89)90852-4","article-title":"Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma","volume":"32","author":"Jenison","year":"1989","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318218f270_bb0015","article-title":"consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)","author":"du Bois","year":"2004","journal-title":"Ann Oncol."},{"key":"10.1097\/IGC.0b013e318218f270_bb0020","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2008.02.006","article-title":"Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cells ovarian cancers","volume":"109","author":"Chan","year":"2008","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318218f270_bb0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1006\/gyno.1996.0065","article-title":"Clear cell carcinoma of the ovary: a distinct histologic type with poor 1068 prognosis and resistance to platinum-based chemotherapy in stage III disease","volume":"60","author":"Goff","year":"1996","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318218f270_bb0030","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2005.12.038","article-title":"Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience","volume":"102","author":"Pectasides","year":"2006","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318218f270_bb0035","first-page":"1238","article-title":"Pattern and clinical predictors of lymph node metastasis in epithelial ovarian cancer. IntJ Gynecol","volume":"17","author":"Harter","year":"2007","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e318218f270_bb0040","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/sj.bjc.6603323","article-title":"Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis","volume":"95","author":"Maggioni","year":"2006","journal-title":"Br J Cancer."},{"key":"10.1097\/IGC.0b013e318218f270_bb0045","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0090-8258(02)00156-7","article-title":"Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma","volume":"88","author":"Ho","year":"2003","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318218f270_bb0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.AOG.0000249610.95885.ef","article-title":"Association of lymphadenectomy and survival in stage I ovarian cancer patients","volume":"109","author":"Chan","year":"2007","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e318218f270_bb0055","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/annonc\/mdn059","article-title":"Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cells carcinoma patients?","volume":"19","author":"Suzuki","year":"2008","journal-title":"Ann Oncol."},{"key":"10.1097\/IGC.0b013e318218f270_bb0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e318218f270_bb0065","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.1996.14.5.1545","article-title":"Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125","volume":"14","author":"Rustin","year":"1996","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318218f270_bb0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc."},{"key":"10.1097\/IGC.0b013e318218f270_bb0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jnci\/95.2.105","volume":"95","year":"2003","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e318218f270_bb0080","first-page":"52","article-title":"Paclitaxel-platinum combination chemotherapy for advanced or recurrent ovarian clear cell adenocarcinoma: a multicenter trial","volume":"16","author":"Utsunomya","year":"2006","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e318218f270_bb0085","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1200\/JCO.2009.25.3617","article-title":"Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials","volume":"28","author":"du Bois","year":"2010","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318218f270_bb0090","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/jnci\/dji102","article-title":"Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial","volume":"97","author":"Benedetti Panici","year":"2005","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e318218f270_bb0095","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.bjc.6603116","article-title":"Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging","volume":"94","author":"Takano","year":"2006","journal-title":"Br J Cancer."},{"key":"10.1097\/IGC.0b013e318218f270_bb0100","first-page":"1353","article-title":"The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study. IntJ Gynecol","volume":"19","author":"Takano","year":"2009","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e318218f270_bb0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ygyno.2004.04.004","article-title":"Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease","volume":"94","author":"Ho","year":"2004","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318218f270_bb0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ygyno.2003.09.030","article-title":"In vitro chemoresistance and biomarker profiles are unique for histologic subtypes of epithelial ovarian cancer","volume":"92","author":"Cloven","year":"2004","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318218f270_bb0115","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00795-004-0252-5","article-title":"K-ras mutation may promote carcinogenesis of endometriosis leading to ovarian clear cell carcinoma","volume":"37","author":"Otsuka","year":"2004","journal-title":"Med Electron Microsc."},{"key":"10.1097\/IGC.0b013e318218f270_bb0120","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1158\/1078-0432.CCR-08-1274","article-title":"Overexpression of class III beta tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinoma","volume":"15","author":"Aoki","year":"2009","journal-title":"Clin Cancer Res."},{"key":"10.1097\/IGC.0b013e318218f270_bb0125","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1525-1438.2007.01156.x","article-title":"Potential benefit of sunitinib in recurrent and refractory ovarian clear cell adenocarcinoma","volume":"18","author":"Rauh-Hain","year":"2008","journal-title":"Int J Gynecol Cancer."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2404564X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2404564X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:13:20Z","timestamp":1753233200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X2404564X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1048891X2404564X"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e318218f270","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical and Medical Treatment of Clear Cell Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e318218f270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2011 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}